Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $45.0200 (-3.84%) ($44.9600 - $47.0000) on Mon. Nov. 14, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.33% (three month average) | RSI | 31 | Latest Price | $45.0200(-3.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -1.1% a day on average for past five trading days. | Weekly Trend | BAX declines -0.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) VYM(51%) SPY(49%) IVE(48%) | Factors Impacting BAX price | BAX will decline at least -0.665% in a week (0% probabilities). TLT(-17%) VIXM(-16%) GDXJ(-9%) UUP(-5%) TIP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.665% (StdDev 1.33%) | Hourly BBV | 0 () | Intraday Trend | -4% | | | |
|
Resistance Level | $47.39 | 5 Day Moving Average | $46.87(-3.95%) | 10 Day Moving Average | $46.93(-4.07%) | 20 Day Moving Average | $47.39(-5%) | To recent high | -8.4% | To recent low | 0% | Market Cap | $22.968b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |